Hedge Fund - Euclidean Capital
Rapt Therapeutics Inc. (RAPT)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q2 (2025-06-30) | $0 | 0% | 0 | $7.63 |
| 2 | 2025 - Q1 (2025-03-31) | $802,637 | 0.3% | 82,237.375 | $9.83 |
| 3 | 2024 - Q4 (2024-12-31) | $1,039,480 | 0.14% | 82,237.375 | $12.70 |
| 4 | 2024 - Q3 (2024-09-30) | $1,322,377 | 0.14% | 82,237.375 | $20.23 |
| 5 | 2024 - Q2 (2024-06-30) | $2,006,592 | 0.25% | 82,237.375 | $46.19 |
| 6 | 2024 - Q1 (2024-03-31) | $5,907,933 | 0.75% | 82,237.375 | $139.03 |
| 7 | 2023 - Q4 (2023-12-31) | $16,348,790 | 1.83% | 82,237.375 | $123.79 |
| 8 | 2023 - Q3 (2023-09-30) | $10,934,281 | 2.38% | 82,237.375 | $163.23 |
| 9 | 2023 - Q2 (2023-06-30) | $10,682,057 | 2.74% | 71,404.125 | $155.76 |
| 10 | 2023 - Q1 (2023-03-31) | $7,943,715 | 6.96% | 54,112.5 | $202.25 |
| 11 | 2022 - Q4 (2022-12-31) | $8,571,420 | 8.01% | 54,112.5 | $160.04 |
| 12 | 2022 - Q3 (2022-09-30) | $10,416,000 | 9.66% | 54,112.5 | $189.15 |
| 13 | 2022 - Q2 (2022-06-30) | $7,900,000 | 6.71% | 54,112.5 | $133.27 |
| 14 | 2022 - Q1 (2022-03-31) | $9,519,000 | 5.53% | 54,112.5 | $188.88 |
| 15 | 2021 - Q4 (2021-12-31) | $15,900,000 | 9.03% | 54,112.5 | $267.29 |
| 16 | 2021 - Q3 (2021-09-30) | $19,722,000 | 9.58% | 79,397.125 | $264.37 |
| 17 | 2021 - Q2 (2021-06-30) | $23,391,000 | 7.59% | 91,975.125 | $186.84 |
| 18 | 2021 - Q1 (2021-03-31) | $16,335,000 | 5.46% | 91,975.125 | $164.88 |
| 19 | 2020 - Q4 (2020-12-31) | $14,532,000 | 3.07% | 91,975.125 | $217.44 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:8.0000 on 2025-06-17
Hedge Fund Resource Center